Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02142062 · ClinicalTrials.gov registry record
Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT02142062 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 100 participants.
The verdict
NCT02142062 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that IVUS identifies more instances of significant iliac and common femoral vein outflow obstruction than multiplanar venography.No hypothesis testing is planned.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02142062
The ClinicalTrials.gov registry entry for NCT02142062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02142062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02142062 about?
NCT02142062 is a clinical study titled "Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction". The purpose of this study is to demonstrate that IVUS identifies more instances of significant iliac and common femoral vein outflow obstruction than multiplanar venography.No hypothesis testing is planned.
What is the current status of trial NCT02142062?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-07. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT02142062?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.